Bacterial Infections  >>  brilacidin (PMX-30063)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
brilacidin (PMX-30063) / Innovation Pharma
NCT02052388: Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Completed
2
215
US
Daptomycin, Cubicin, Brilacidin, PMX63
Cellceutix Corporation
Skin Infection, Bacterial Infection
10/14
10/14

Download Options